[Prostate cancer: synopsis of the American Urological Association (AUA) 2006].
The 2006 annual American Urological Association (AUA) meeting took place in Atlanta from 20-25th of May. Four hundred and seventy nine abstracts (27.8%) were dedicated to the prostate cancer. The aim of this study is to summarise the most debated topics and to highlight the most original research. The main topics this year were obesity, ethnicity, PSA kinetic, surgical margins, robot and adjuvant therapy.
Culty
T
T
Service d'urologie, CHU de la Pitié-Salpêtrière, 47-83, boulevard de Hôpital, 75651 Paris 13, France. thibautculty@yahoo.com
Richard
F
F
D000726:Androgen Antagonists / Q000627:therapeutic use; D001706:Biopsy; D006801:Humans; D010535:Laparoscopy; D008197:Lymph Node Excision; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000628:therapy; D009765:Obesity / Q000453:epidemiology; D010024:Osteoporosis / Q000139:chemically induced / Q000517:prevention & control; D011467:Prostate / Q000473:pathology; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000453:epidemiology / Q000473:pathology* / Q000628:therapy*; D012307:Risk Factors; D012371:Robotics; D016879:Salvage Therapy; D014481:United States
D000726:Androgen Antagonists; D017430:Prostate-Specific Antigen